文献速递心律失常

SCN5A非编码增强子罕见变异与泰国Brugada综合征高患病率相关

A Rare Noncoding Enhancer Variant in SCN5A Contributes to the High Prevalence of Brugada Syndrome in Thailand.
PubMed 文献 · Circulation · 2024-10-11

该研究对泰国Brugada综合征先证者及人群对照进行基因组测序,在SCN5A内含子增强子区发现一个罕见非编码变异,病例携带率3.9%,病例对照比值比45.2。该变异经CRISPR-Cas9引入hiPSC-CMs后导致含变异等位基因的SCN5A表达下降及Nav1.5钠电流密度降低30%,携带者中89%发生心脏骤停。

要点

  • SCN5A内含子增强子罕见变异在泰国Brugada综合征病例中携带率3.9%,比值比45.2。
  • 该变异破坏Mef2转录因子结合位点,hiPSC-CMs中Nav1.5钠电流密度降低30%。
  • 变异携带者表型严重,89%经历心脏骤停。

核心结论

  • 该研究首次功能验证了SCN5A位点一个罕见非编码变异,部分解释泰国Brugada综合征患病率升高,并支持识别高危变异携带者以减少心脏性猝死负担。

研究设计与样本

  • 对泰国Brugada综合征先证者与人群匹配对照进行基因组测序,筛选SCN5A-SCN10A位点富集于患者的罕见非编码变异。
  • 通过计算方法优先排序可能 causal 的变异,并用CRISPR-Cas9引入人诱导多能干细胞,评估对SCN5A表达及Nav1.5钠电流的影响。

主要发现

  • 一个SCN5A内含子增强子区罕见非编码变异在Brugada综合征患者中高度富集,病例携带率3.9%,病例对照比值比45.2。
  • 该变异影响所有哺乳动物中保守的核苷酸,预测破坏Mef2转录因子结合位点。
  • hiPSC-CMs中杂合引入该增强子变异导致含变异等位基因的SCN5A表达显著降低,Nav1.5介导的钠电流密度较同基因对照降低30%。
  • 携带该变异的患者表型严重,89%经历心脏骤停。

临床怎么用

  • 在泰国Brugada综合征患者中检测该SCN5A增强子变异有助于识别高危携带者,以针对性降低心脏性猝死负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Brugada syndrome (BrS) is a cardiac arrhythmia disorder that causes sudden death in young adults. Rare genetic variants in the SCN5A gene encoding the Nav1.5 sodium channel and common noncoding variants at this locus are robustly associated with the condition. BrS is particularly prevalent in Southeast Asia but the underlying ancestry-specific factors remain largely unknown. METHODS: Genome sequencing of BrS probands and population-matched controls from Thailand was performed to identify rare noncoding variants at the SCN5A-SCN10A locus that were enriched in patients with BrS. A likely causal variant was prioritized by computational methods and introduced into human induced pluripotent stem cell (hiPSC) lines using CRISPR-Cas9. The effect of the variant on SCN5A expression and Nav1.5 sodium channel current was then assessed in hiPSC-derived cardiomyocytes (hiPSC-CMs). RESULTS: A rare noncoding variant in an SCN5A intronic enhancer region was highly enriched in patients with BrS (detected in 3.9% of cases with a case-control odds ratio of 45.2). The variant affects a nucleotide conserved across all mammalian species and predicted to disrupt a Mef2 transcription factor binding site. Heterozygous introduction of the enhancer variant in hiPSC-CMs caused significantly reduced SCN5A expression from the variant-containing allele and a 30% reduction in Nav1.5-mediated sodium current density compared with isogenic controls, confirming its pathogenicity. Patients with the variant had severe phenotypes, with 89% experiencing cardiac arrest. CONCLUSIONS: This is the first example of a functionally validated rare noncoding variant at the SCN5A locus and highlights how genome sequencing in understudied populations can identify novel disease mechanisms. The variant partly explains the increased prevalence of BrS in this region and enables the identification of at-risk variant carriers to reduce the burden of sudden cardiac death in Thailand.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Walsh R, Mauleekoonphairoj J, Mengarelli I, et al. A Rare Noncoding Enhancer Variant in SCN5A Contributes to the High Prevalence of Brugada Syndrome in Thailand. Circulation. 2024. PMID: 39391988. doi:10.1161/CIRCULATIONAHA.124.069041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。